Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.25%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +35.58%
#5 Humanity Humanity +26.67%
#6 Codatta Codatta +18.76%
#7 Walrus Walrus +18.15%
#8 Enso Enso +18.11%
#9 The Black Bull The Black Bull +14.64%
#10 Collector Crypt Collector Crypt +14.30%
Coin of the day
EXOD EXOD
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Pozycja w akcjach #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Cena akcji
$0.117
Ostatnia synchronizacja: 2025-04-04
Kapitalizacja rynkowa
$2.45M
Zmiana (1 dzień)
-13.59%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Carmell Therapeutics Corporation (CTCX)

Kategoria

Healthcare
Wskaźnik P/S dla Carmell Therapeutics Corporation (CTCX)
Wskaźnik P/S na dzień August 2026 TTM: 3.52
Według najnowszych raportów finansowych i ceny akcji Carmell Therapeutics Corporation, obecny wskaźnik P/S (TTM) wynosi 3.52. Na koniec 2023 wynosił 0.00.
Historia wskaźnika P/S dla Carmell Therapeutics Corporation od 2021 do 2026
Wskaźnik P/S na koniec każdego roku
Rok Wskaźnik P/S Zmień
2026 (TTM) 3.52 -99.90%
2024 3.48K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
Wskaźnik P/S dla podobnych firm lub konkurentów
Firma Wskaźnik P/S Różnica wskaźnika P/S Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 188.58%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 187.49%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 34.60%
BE